🇺🇸 FDA
Patent

US 8968719

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 8968719 (Live, oral vaccine for protection against Shigella dysenteriae serotype 1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/0283, A61K48/00